SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors focus on the potential for a gamma squeeze driven by high call option interest and imminent data readouts from the AACR conference. The community remains deeply divided, with bulls highlighting the long survival tails in clinical trials as evidence of therapeutic success, while bears express skepticism regarding trial design consistency and regulatory approval hurdles.

Daddy Darth Sidious

Investors are fueling speculation around SIDIOUS and DARTH, with the community actively debating whether a sector-wide rotation away from rival tokens is underway. Discussions are centered on potential momentum plays as participants urge others to buy the dip while navigating concerns over market volatility and project sustainability.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

The 401jK community is actively promoting its retirement-focused narrative as a protest against traditional financial systems, driving engagement through consistent community-led initiatives and viral meme content. Despite broader market volatility, supporters remain bullish on the long-term potential of the project, highlighting its active subreddit and grassroots involvement.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as investors monitor the anticipation of the April 30, 2026, PDUFA date for AXS-05, a pivotal regulatory catalyst for Alzheimer's disease-associated agitation. The community is actively discussing the company's aggressive expansion of its sales force and strong prescription growth for Auvelity, while analysts continue to adjust price targets upward in response to high conviction in the drug's approval prospects.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

RETIRE is trending as the community positions the token as a disruptive, decentralized alternative to traditional 401(k) retirement funds. Investors are actively sharing DCA strategies and bullish narratives about achieving financial freedom through this grassroots movement.

Daddy Darth Vader

The community is actively engaged in a rivalry known as the 'Daddy Wars' between $DARTH, $MAULCOIN, and the newly launched $SIDIOUS. Investors are debating the long-term viability of these meme tokens, with discussions heavily focused on liquidity management, the transparency of project developers, and strategic rotation between the competing assets.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binance is trending as the exchange takes proactive measures against fraudulent activity, including offering a bounty to track down fake listing agents. Community sentiment remains focused on the exchange's security initiatives and the potential long-term price action of BNB.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors highlight its strategic positioning within the NVIDIA quantum ecosystem, with many in the community comparing its current valuation favorably against sector peers like IONQ and Rigetti. Discussion is dominated by the company's dual role in calibration and decoding, driving bullish sentiment regarding its long-term potential in defense and space applications despite short-term volatility surrounding share lock-up expirations.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is seeing increased investor attention as the community anticipates critical clinical data readouts and potential regulatory milestones. Shareholders are actively debating the company's valuation relative to recent industry acquisitions, focusing on the upcoming prostate cancer data as a primary catalyst for a long-awaited revaluation.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as supporters highlight its origin story dating back to 2011, positioning it as the original foundational memecoin before the current cycle of tokens. Community members are actively debating its narrative depth versus its ironic roots, while bullish investors emphasize the involvement of the original founder and large-scale, locked supply holdings as evidence of long-term viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KBC Group NV Boosts Stock Holdings in IQVIA Holdings Inc. $IQV

KBC Group NV lifted its holdings in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 68.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 779,128 shares of the medical research company's stock after purchasing an additional 315,883 shares during the period. KBC...

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will...

Massachusetts Financial Services Co. MA Buys 27,510 Shares of IQVIA Holdings Inc. $IQV

Massachusetts Financial Services Co. MA increased its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 13.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 226,646 shares...

Assetmark Inc. Purchases 43,436 Shares of IQVIA Holdings Inc. $IQV

Assetmark Inc. grew its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 33.6% during the fourth quarter, according to the company in its most recent filing with the Securities and...

IQVIA Holdings Inc. $IQV Stock Holdings Lessened by Running Oak Capital LLC

Running Oak Capital LLC trimmed its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the...

Hardman Johnston Global Advisors LLC Has $24.77 Million Holdings in IQVIA Holdings Inc. $IQV

Hardman Johnston Global Advisors LLC lessened its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 8.2% during the 4th quarter, according to its most recent filing with the...

Sumitomo Mitsui Trust Group Inc. Acquires 332,505 Shares of IQVIA Holdings Inc. $IQV

Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 41.6% during the fourth quarter, according to its most recent 13F filing with the SEC...

IQVIA (NYSE:IQV) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen lowered IQVIA from a "buy" rating to a "hold" rating in a report on Saturday...

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why You Should Retain IQV Stock in Your Portfolio Now

IQVIA's AI push with NVIDIA, strategic deals and buybacks drive growth, but weakening liquidity raises concerns over near-term financial flexibility.

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Current Price	$176.46
Prev Close	$171.95
Open	$174.40
Dividend Yield	0.00%
50-Day Moving Average	$171.29
Beta	1.13
Avg. Volume	1.62M
PE Ratio	22.46

52-Week High	$247.05
52-Week Low	$134.65
Market Capitalization	$29.18B
EPS (Annual)	$7.84
Price to Book	4.60
Revenue Per Employee	$175,311.83

IQV
IQVIA Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IQV News

IQVIQVIA Holdings Inc